Get to know AUBAGIO
AUBAGIO is a once-daily pill used to treat relapsing forms of MS that has been shown to quiet MS. AUBAGIO® (teriflunomide) is effective across key measures of disease activity: sustained disability progression (14 mg only), annualized relapse rate, and MRI activity. Overall discontinuation rates due to adverse events were 12.5% with AUBAGIO 14 mg, 11.2% with AUBAGIO 7 mg, and 7.5% with placebo, and treatment discontinuation rates due to common adverse events were ≤3.3% in the pooled clinical trials.
This pill can be taken any time of day, any place, with or without food. It does not need to be taken at exactly the same time each day. AUBAGIO is available in two strengths, 7 mg and 14 mg, and the more commonly prescribed strength is 14 mg. Your healthcare provider will decide which one is right for you.
Important things to know about AUBAGIO
AUBAGIO 14 mg was shown to be effective vs placebo in 3 key measures of disease activity—relapses, brain lesions, and disability progression*—in clinical trials.
AUBAGIO 7 mg was shown to be effective in 2 of those 3 key measures—relapses and brain lesions—in clinical trials.
2. AUBAGIO IS ONE PILL, ONCE A DAY
Your healthcare provider will run certain tests before you start treatment. Once on AUBAGIO, your healthcare provider will monitor your liver enzyme levels monthly for the first 6 months.
*Doctors measure disability progression using a test called the Expanded Disability Status Scale, or EDSS. Your first score — or your "baseline" — will determine how your disability is gauged moving forward. If your baseline score is ≤ 5.5, you're considered to have sustained disability progression if that score goes up by one point (lasting at least 12 weeks). If your baseline score is > 5.5 you're considered to have sustained disability progression if that score goes up by at least 0.5 points (lasting at least 12 weeks).
AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after.
Tell your doctor if you have any side effect that bothers you or does not go away.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results.
With AUBAGIO, your healthcare provider will run tests within 6 months before you start treatment: perform blood tests to check your liver; obtain a complete blood count; perform a TB (tuberculosis) skin test or blood test for mycobacterium tuberculosis infection; check your blood pressure; and perform a pregnancy test, if you are a woman of childbearing potential.
After starting treatment, your healthcare provider will monitor your liver enzyme levels monthly for the first 6 months, and check your blood pressure periodically.
“AUBAGIO is a pill — I don't have to think about my medication once I take it in the morning.”
Individual experiences may vary.
Diagnosed: 1997See Darin's full story
Contact an MS One
to One® Nurse
Get support, even if you're not taking AUBAGIO.Learn more
Get facts and answers about relapsing MS, AUBAGIO, and more.Learn more
Get AUBAGIO Viewpoints
Real people with relapsing MS on AUBAGIO share their thoughts on treatment and MS.Learn more